Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Spdr S&P Biotech Etf
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
Vertex kidney drug Povetacicept succeeds in IgAN trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its…
In the fight against cystic fibrosis, Boomer Esiason and his son Gunnar win
When NFL quarterback Boomer Esiason was about to walk onto the New York Jets' practice field in 1993, shortly after…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
FDA Official Discusses UniQure Gene Therapy for Huntington's Disease
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure needs to conduct another study to show that…